Clinical Trials on Osteoporosis Risk in Russian Federation
Total 41 results
-
Eli Lilly and CompanyCompletedOsteoporosis, Post-MenopausalRussian Federation
-
Tver Regional Perinatal CenterCompletedObstetric Anesthesia Problems | High-Risk PregnancyRussian Federation
-
University of Illinois at ChicagoNational Institute on Drug Abuse (NIDA); Prisma Research CenterCompletedHIV Infections | Hepatitis C | Risk Reduction Behavior | Risky Health BehaviorRussian Federation
-
Atlas BiomedWithdrawnInflammation | Metabolic Syndrome | Dyslipidemias | Cardiovascular Risk Factor | MicrobiomeRussian Federation
-
Center of Personalized Medicine, PirogovaUniversity of Rochester; I.M. Sechenov First Moscow State Medical University; Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health and other collaboratorsCompletedAdherence to Personalized EBM Anticoagulant Treatment in Patients at High Risk for StrokeRussian Federation
-
Meshalkin Research Institute of Pathology of CirculationUnknownPulmonary Embolism | Intermediate-high Risk | Combination of Oral Anticoagulation Therapy and SildenafilRussian Federation
-
Federal Research Institute of Pediatric Hematology...RecruitingAcute Myeloid Leukemia | Myelodysplastic Syndromes | Acute Lymphoblastic Leukemia, in Relapse | Non-hodgkin Lymphoma | High Risk Acute Myeloid Leukemia | High Risk Acute Lymphoblastic Leukemia | Acute Biphenotypic Leukemia in RelapseRussian Federation
-
Tomsk National Research Medical Center of the Russian...RecruitingCOVID-19 | Risk Factors | Polypharmacy | Drug Interactions | Self MedicationRussian Federation
-
National Medical Research Center for Children's...RecruitingVitamin D Deficiency | Osteoporosis | Osteopenia | Phosphorus and Calcium Disorders | Bullosa EpidermolysisRussian Federation
-
Moscow Clinical Scientific CenterRecruitingBreast Cancer | Solid Tumor | Gastrointestinal Cancer | Gynecological Malignancies | High-Risk Cancer | MyelosuppressionRussian Federation
-
Federal State Budgetary Institution, V. A. Almazov...CompletedIncreased Risk of SARS-CoV-2 InfectionRussian Federation
-
Eurasian Association of TherapistsCompletedDiabetes | Covid19 | Death | Atrial Fibrillation | Risk Factor, Cardiovascular | CKD | COPD | Comorbidities and Coexisting Conditions | DVTRussian Federation
-
Federal State Budgetary Institution National Medical...Kemerovo Cardiology Center, Tarasov Roman Sergeevich; Tomsk National Research...RecruitingCoronary Syndrome, Acute, Non-ST Elevation, High Risk PatientsRussian Federation
-
Hoffmann-La RocheCompletedPostmenopausal OsteoporosisPoland, Slovakia, Hungary, Russian Federation, Latvia, Romania, Slovenia
-
AmgenCompletedOsteoporosis in MenUnited States, Belgium, Colombia, Czechia, Denmark, Japan, Mexico, Poland, Russian Federation, Switzerland
-
AstraZenecaCompletedPostoperative or Postradiation Adjuvant Androgen Deprivation Therapy in Locally Advanced Prostate Cancer (High and Very High Risk) PatientsRussian Federation
-
Teva Pharmaceuticals USATeva Branded Pharmaceutical Products R&D, Inc.CompletedOsteoporosis, PostmenopausalUnited States, Bulgaria, Czechia, Georgia, Germany, Hungary, Poland, Russian Federation, Slovakia, Ukraine
-
Novartis PharmaceuticalsCompletedOsteoporosisAustralia, Canada, Russian Federation, Hungary, South Africa, United Kingdom
-
Novartis PharmaceuticalsCompletedOsteoporosisAustralia, Canada, Russian Federation, Hungary, South Africa, United Kingdom
-
AmgenCompletedEvaluate the Safety and Efficacy of Denosumab in Pediatric Subjects With | Glucocorticoid-induced OsteoporosisUnited States, Bulgaria, Turkey, Italy, Australia, Belgium, Canada, Colombia, India, Mexico, Peru, Russian Federation, Ukraine
-
Medtronic BRCCompletedAtrial Fibrillation | Risk of Cardiac ArrhythmiasNetherlands, Germany, Austria, Belgium, Canada, Czech Republic, Russian Federation, Slovakia
-
ShireCompletedOsteoporosisUnited States, Argentina, Canada, Brazil, Bulgaria, Israel, Mexico, Romania, Russian Federation
-
Novartis PharmaceuticalsCompletedMale OsteoporosisRussian Federation, Argentina, Switzerland, United Kingdom, Germany, Belgium, Czechia, Finland, Spain, Brazil, Romania, Hungary, Denmark, Poland, Norway, Sweden, Austria, South Africa, Slovakia, Australia, Iceland, Italy, Portugal
-
GlaxoSmithKlineTerminatedOsteoporosisGermany, Russian Federation, Korea, Republic of, United States, Belgium, Hong Kong, Spain, Australia, Argentina, South Africa, Poland, Norway, Mexico, Denmark
-
AmgenCompletedPostmenopausal Women With OsteoporosisUnited States, Canada, Denmark, France, Germany, Italy, Belgium, Colombia, Czechia, Mexico, Poland, Russian Federation, Netherlands, Hungary, Peru, Turkey, Taiwan, Spain, Hong Kong, Austria, Slovakia, United Kingdom, South Africa, Aus... and more
-
OctapharmaCompletedSignificant Bleeding RiskRussian Federation, United States, Romania, Ukraine, Belarus, Bulgaria, Georgia, Germany, Moldova, Republic of, Poland, Spain
-
SanofiBristol-Myers SquibbTerminatedAtrial Fibrillation | Vascular RiskUnited States, France, Canada, Brazil, Poland, Russian Federation, Australia, Germany, Italy, Netherlands, Portugal, Spain, Sweden, Switzerland, Turkey, Malaysia, Singapore, Taiwan, Belgium, Czech Republic, Mexico, Denmark, Finland, H... and more
-
ShireCompletedOsteoporosisUnited States, Argentina, Canada, Brazil, Israel, Mexico, Romania, Russian Federation
-
Boston Scientific CorporationCompletedPatients With Atrial Fibrillation at Risk for Thrombus Formation, Thromboembolism, StrokeIreland, Spain, Germany, Netherlands, France, United Kingdom, Italy, Russian Federation, Portugal, Belgium, Poland, Saudi Arabia, United Arab Emirates
-
Ligand PharmaceuticalsCompletedOsteoporosisUnited States, Australia, Canada, Costa Rica, Germany, Russian Federation, France, Croatia, South Africa, Belgium, Japan, India, Spain, United Kingdom, Italy, Egypt, Turkey, Lithuania, Poland, Norway, Estonia, Finland, Denmark, Hong Kong and more
-
PfizerCompletedOsteoporosisUnited States, Canada, France, Greece, Germany, Argentina, Chile, Croatia, South Africa, Belgium, Italy, Spain, Australia, Bulgaria, Hong Kong, Poland, Finland, Slovakia, Russian Federation, Brazil, Norway, New Zealand, Lithuania, Est... and more
-
Population Health Research InstituteCanadian Institutes of Health Research (CIHR); Heart and Stroke Foundation...RecruitingCardiovascular Diseases | Lung Diseases | Cancer | Risk Factor, Cardiovascular | Health Behavior | Injuries | Environmental Exposure | Renal Disease | Communicable DiseaseIndia, Saudi Arabia, Iran, Islamic Republic of, Peru, Pakistan, Argentina, Bangladesh, Brazil, Canada, Chile, China, Colombia, Kazakhstan, Kyrgyzstan, Malaysia, Palestinian Territory, occupied, Philippines, Poland, Russian Federation and more
-
Novartis PharmaceuticalsTerminatedMyelofibrosis With High Molecular Risk MutationsBelgium, Spain, United Kingdom, Hungary, Italy, Japan, Taiwan, Germany, Canada, Singapore, Austria, Australia, France, Israel, Sweden, Switzerland, Hong Kong, Greece, Turkey, Brazil, Russian Federation, Denmark, Portugal, Norway, Poland
-
Bristol-Myers SquibbCompletedHigh Risk Stage III MelanomaItaly, Poland, United Kingdom, United States, Netherlands, Spain, Australia, France, Germany, Canada, Russian Federation, Belgium, Norway, Switzerland, Sweden, Finland, Austria, Denmark, Czechia
-
Advaxis, Inc.Gynecologic Oncology GroupTerminatedHigh Risk Cervical Cancer | Advanced Cervical CancerUnited States, Argentina, Brazil, Canada, Chile, Korea, Republic of, Malaysia, Mexico, Poland, Russian Federation, Serbia, Spain, Taiwan, Ukraine
-
Janssen Research & Development, LLCThe George Institute for Global Health, AustraliaCompletedCardiovascular Diseases | Diabetes Mellitus, Type 2 | Risk FactorsUnited States, Australia, Poland, Ukraine, United Kingdom, Belgium, Germany, France, Spain, Argentina, Colombia, Israel, Mexico, India, Canada, Netherlands, Sweden, Malaysia, New Zealand, Estonia, Russian Federation, Hungary, Norway, ... and more
-
AmgenCompletedCancer | Cataract | Prostate Cancer | Osteoporosis | Osteopenia | Low Bone Mineral DensityUnited States, Canada, Czechia, Poland, Russian Federation, Slovakia, Hungary, South Africa, Greece, Bulgaria, France, Ukraine, Australia, Latvia, India, Slovenia, New Zealand, Mexico
-
AstraZenecaThe Cleveland Clinic; IQVIA RDS Inc.CompletedEligible Men or Women Considered High Risk for Atherosclerotic Cardiovascular Disease (CVD)United States, Belgium, Italy, Netherlands, Denmark, Taiwan, Poland, Russian Federation, Korea, Republic of, Hungary, United Kingdom, China, New Zealand, Czechia, Australia, South Africa, Ukraine, Japan, Canada, Mexico, Lithuania, Estoni...
-
AstraZenecaCompletedSmoking | Hypertension | Obesity | Diabetes | Hyperlipidemia | Cardiovascular Risk FactorsSweden, France, Russian Federation, Spain, Turkey, United Kingdom, Germany, Norway, Austria, Belgium, Switzerland, Greece
-
AstraZenecaBristol-Myers Squibb; Hadassah Medical Organization; The TIMI Study GroupCompletedDiabetes Mellitus, Non-Insulin-Dependent | High Risk for Cardiovascular EventUnited States, Canada, France, Italy, Netherlands, Spain, Belgium, Thailand, Vietnam, Bulgaria, Korea, Republic of, Brazil, Philippines, Russian Federation, Turkey, Taiwan, Australia, Israel, South Africa, Germany, Japan, Czechia, H... and more
-
Novo Nordisk A/SRecruitingInflammation | Chronic Kidney Disease | Cardiovascular RiskKorea, Republic of, Italy, United States, Spain, China, Taiwan, Mexico, Netherlands, Latvia, Malaysia, Thailand, Hungary, Australia, Poland, South Africa, India, Canada, Portugal, Romania, United Kingdom, Bulgaria, Germany, Brazil, Sw... and more